HIV-associated wasting in the HAART era: guidelines for assessment, diagnosis, and treatment.
about
Clinical utility of dronabinol in the treatment of weight loss associated with HIV and AIDSEffects of anabolic-androgens on brain reward functionPotential benefits of cyproheptadine in HIV-positive patients under treatment with antiretroviral drugs including efavirenz.Vitamin D status and its association with morbidity including wasting and opportunistic illnesses in HIV-infected women in Tanzania.Ethnicity and Smoking-Associated DNA Methylation Changes at HIV Co-Receptor GPR15The Effect of HIV and the Modifying Effect of Anti-Retroviral Therapy (ART) on Body Mass Index (BMI) and Blood Pressure Levels in Rural South Africa.Recombinant human growth hormone therapy in HIV-associated wasting and visceral adiposity.Vitamin D status and incidence of pulmonary tuberculosis, opportunistic infections, and wasting among HIV-infected Tanzanian adults initiating antiretroviral therapy.Association of serum albumin concentration with mortality, morbidity, CD4 T-cell reconstitution among tanzanians initiating antiretroviral therapyUse of Dronabinol Improves Appetite and Reverses Weight Loss in HIV/AIDS-Infected Patients.Depression at antiretroviral therapy initiation and clinical outcomes among a cohort of Tanzanian women living with HIV.Factors associated with undernourishment among people 20 years old or over with HIV/AIDS, attending public health services in the São Paulo municipality, Brazil.Effect of BMI and fat mass on HIV disease progression in HIV-infected, antiretroviral treatment-naïve adults in Botswana.Lack of effect of recombinant human growth hormone on the in vitro activities of antiretroviral drugs against human immunodeficiency virus type 1Concerning "Effects of a supraphysiological dose of testosterone on physical function, fatigue, and mood in men with human immunodeficiency virus-associated weight loss".Nutritional status in patients with HIV infection and AIDS.
P2860
Q26765257-8EB51962-58FA-4A61-BD48-A7DC22D61871Q26785394-784D3AE0-FA65-4992-8CCB-F3460A8488C8Q34310827-09FAE5BE-25DA-455F-B843-197E3AC65295Q35245597-75ACD058-F861-4E06-B636-641BE4FC13B8Q36097654-61D3AF23-F068-4820-B748-577949C290F0Q36110344-6284684E-A2FB-4446-A57C-3FB5EF99F610Q36278045-807E45DE-66B4-4BC1-99CB-4C5250F6803BQ36509827-F13AD4DC-4567-4367-A09F-DE4CABA3F38CQ36723329-9C24C2CE-0A31-403A-BD0E-92AC964B7278Q36835326-041B0E90-B0FD-4B4A-9273-C31E279125C4Q40479662-52B1C4C9-D92F-476A-8902-1357347DA4CBQ40654092-02ACEE9F-EF7D-45C5-B2CC-74AE3D8663BAQ40710920-B4569CE7-396D-44AF-BDFE-7072E673AD61Q40882575-EC8668DF-9197-4010-8BE1-07660980A42AQ45390275-DA83980E-2528-41CB-9E14-BF6384607D2DQ46960950-EB26CCB1-8661-4368-A51D-1F45BD5F7282
P2860
HIV-associated wasting in the HAART era: guidelines for assessment, diagnosis, and treatment.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
HIV-associated wasting in the ...... ent, diagnosis, and treatment.
@ast
HIV-associated wasting in the ...... ent, diagnosis, and treatment.
@en
HIV-associated wasting in the ...... ent, diagnosis, and treatment.
@nl
type
label
HIV-associated wasting in the ...... ent, diagnosis, and treatment.
@ast
HIV-associated wasting in the ...... ent, diagnosis, and treatment.
@en
HIV-associated wasting in the ...... ent, diagnosis, and treatment.
@nl
prefLabel
HIV-associated wasting in the ...... ent, diagnosis, and treatment.
@ast
HIV-associated wasting in the ...... ent, diagnosis, and treatment.
@en
HIV-associated wasting in the ...... ent, diagnosis, and treatment.
@nl
P2093
P1476
HIV-associated wasting in the ...... ent, diagnosis, and treatment.
@en
P2093
P304
P356
10.1089/108729101316914412
P577
2001-08-01T00:00:00Z